AVENTIS ASSIGNS TAXOTERE TO HILL AND KNOWLTON
By Adnews Staff
Hill and Knowlton Canada has been appointed the agency of record for Aventis Pharma's Taxotere product. The account will be handled by the agency's health and pharmaceutical practice. Two additional unnamed agencies were also considered. Previously the account was handled in-house. Taxotere is used in the treatment of breast, lung, ovarian, head and neck cancer. The Toronto Fire Fighters' Association assigned Hill and Knowlton a public awareness campaign earlier this week that will promote new international fire service standards.
« Back Next »
Comments
blog comments powered by Disqus